Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

US Patent 6723731 · Granted Apr 20, 2004

Estimated economic value: $3,314,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral dosing of GLP-1 compounds2025
Glucose-sensitive albumin-binding derivatives2025
Glucose-sensitive albumin-binding derivatives2023
GLP-1 derivatives and uses thereof2023
Glucose sensitive insulins and uses thereof2023
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2022
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2022
Glucose-sensitive albumin-binding derivatives2021
Tablet formulation comprising a GLP-1 peptide and a delivery agent2021
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2021
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2021
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2019